ChaNaWiT/iStock via Getty Images “Hurry up and wait” remains the order of the day for Merit Medical (NASDAQ:MMSI) and its shareholders. While the company has executed pretty well since my last update (some revenue and EBITDA outperformance), and the shares are up about 20%, I suspect there may be some investor frustration that there hasn’t been more news to drive a fundamental shift in investment theses – the company has been reasonable (if not conservative) with guidance, hasn’t done any big M&A, and h ...